Stellar Biotechnologies Inc Stock Nasdaq
Equities
CA85855A3029
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 13.35M 18.24M |
---|---|---|---|---|---|
Net income 2024 * | -8M -10.94M | Net income 2025 * | -10M -13.67M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.13
x | P/E ratio 2025 * |
-2.49
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.93% |
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 07-06-11 |
Michael Brooks
PSD | President | 46 | 15-08-31 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 23-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 19-06-06 |
Frank Oakes
BRD | Director/Board Member | 73 | 10-04-08 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23-05-22 |
1st Jan change | Capi. | |
---|---|---|
+16.45% | 122B | |
+21.96% | 116B | |
+25.71% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-15.89% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |